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miR-21 enhances cardiac fibrotic
remodeling and fibroblast proliferation via
CADM1/STAT3 pathway
Wei Cao1,2, Peng Shi2 and Jian-Jun Ge1,3*
Abstract
Background: Cardiac fibrosis play a key role in the atrial fibrillation pathogenesis but the underlying potential
molecular mechanism is still understood. However, potential mechanisms for miR-21 upregulation and its role in
cardiac fibrosis remain unclear. The controls cell proliferation and processes fundamental to disease progression.
Methods: In this study, immunohistochemistry, real-time RT-PCR, cell transfection, cell cycle, cell proliferation and
Western blot were used, respectively.
Results: Here we have been demonstrated that the tumor suppressor cell adhesion molecule 1 (CADM1) is the
potential target of miR-21. Our study revealed that miR-21 regulation of CADM1 expression, which was decreased
in cardiac fibroblasts and fibrosis tissue. The cardiac fibroblasts transfected with miR-21 mimic promoted miR-21
overexpression enhanced STAT3 expression and decreased CADM1 expression. Nevertheless, the cardiac fibroblasts
transfected with miR-21 inhibitor obtained the opposite expression result. Furthermore, downexpression of miR-21
suppressed cardiac fibroblast proliferation.
Conclusions: These results suggested that miR-21 overexpression promotes cardiac fibrosis via STAT3 signaling
pathway by decrease CADM1 expression, indicating miR-21 as an important signaling molecule for cardiac fibrotic
remodeling and AF.
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Background
Atrial fibrillation (AF) is considered to be an indication
of underlying heart disease and is one of the most com-
mon cardiac arrhythmia disorders [1]. Cardiac remodel-
ing, especially the structural remodeling, is a key result
of AF [2]. Cardiac fibroblasts activation and aberrant
fibroblast signaling can lead to cardiac fibrosis and heart
injury [3]. Reports showed that cardiac remote ischaemic
preconditioning can reduce periprocedural myocardial
infarction in the percutaneous coronary interventions
patients [4]. However, the molecular mechanisms of car-
diac remodeling during atrial fibrillation remain incom-
pletely understood.
MicroRNAs (miRs), small endogenous non-coding
RNAs, about 19–22 nt functional RNA molecule, play
important regulatory roles by sequence-specific base
pairing on the 3' untranslated region (3'-UTR) of target
messenger RNAs (mRNAs) [5]. miRs can post-
transcriptionally silence protein expression either by
binding to complementary target mRNAs and degrading
these mRNAs, or by inhibiting mRNAs translating into
proteins [6]. miRs are emerging as important regulators
in participate in cell proliferation, differentiation, and
apoptosis [7]. The effect of miR-21 on cardiac fibrosis
has been well established [8, 9]. However, the precise
function of miR-21 in cardiac fibrosis is still unclear.
Cell adhesion molecule 1 (CADM1), an immunoglobu-
lin superfamily (Igsf ) adhesion molecule, is a well-
known tumor suppressor for a variety of cancers of epi-
thelial origin [10]. CADM1 downregulation may through
epigenetic silencing [11]. In immortalized kidney cells,
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the extracellular domain of CADM1 binds the receptor
tyrosine kinase HER3, reducing cell proliferation [12].
CADM1 is representative cardio-miRs targets [13]. miRs
regulate STAT3 signaling cascades that are involved in
cardiac fibrosis as well as pathogenesis of human dis-
eases [13]. STAT3 an important regulator of cell prolifer-
ation [14]. STAT3 is a downstream signaling molecule of
CADM1 [15]. Currently, recent studies demonstrated
that CADM1 suppress squamous cell carcinoma devel-
opment through decreasing STAT3 activity [15].
This study was able to investigate the role of miR-21
and CADM1 in cardiac fibrosis and potential interaction
between miR-21 and CADM1. More importantly, miR-
21 inhibitor repressed cardiac fibrosis progression, miR-
21 may be a better alternative to directly inhibit CADM1
expression in cardiac fibrosis. Our studies further sup-
port miR-21 acts as important regulators in participate
in cardiac fibrosis pathological, enhances cardiac fibrotic




Isoprenaline was obtained from He Feng (Shanghai,
China). α-SMA and collagen I antibodies for were
purchased from Boster (Wuhan, China), CADM1, p-
STAT3 antibodies were obtained from Cell Signaling
(Beverly, MA, USA). The primers of CADM1, STAT3,
α-SMA, collagen I and β-actin were produced by
Shanghai Sangong Biological and Technological Company
(Shanghai, China). Immunohistochemical kit was obtained
from the Zhongshan Biotechnology Corporation (Beijing,
China). SYBR Green Real Master Mix and Reverse tran-
scription reaction Mix were purchased from Fermentas
(Ontario, Canada). Goat anti-rabbit IgG horse radish
peroxidase (HRP), rabbit anti-goat IgG HRP, goat
anti-mouse IgG HRP were obtained from Santa Cruz
(California, USA).
Animals and treatments
Sprague–Dawley (SD) rats (weight 180–230 g) were pur-
chased from the Experimental Animal Center of Anhui
Medical University. SD rats were randomly divided into
vehicle group and model group. In the model group, we
use the method of ISO (2.4 mg/kg/day, 7 days, n = 15)
subcutaneous injection. The vehicle object treated the
same procedure, and the only difference was that normal
saline instead of ISO. After 1 week, heparin injection
(625U/100 g), deep anesthesia was induced with pento-
barbital (50 mg/100 g body weight), the rats were anes-
thetized and killed (the cervical dislocation: is the most
common method of death in rat. With the thumb and
index finger pressed down the rat head, the other hand
to seize the tail, forced a little back above the pull, so
that the cervical off, causing the spinal cord and brain
marrow off, animals immediately died), hearts were
quickly isolated and heart tissue specimens were fixed in
4% phosphate-buffered paraformaldehyde. Other heart
tissue specimens were snap-frozen in liquid nitrogen
and stored at –80 °C for molecular analysis.
Patients and sample acquisition
All patients gave written informed consent to participate
in this study, and the Institutional Ethics Committee of
The First Hospital of Anhui Medical University (Anhui,
China) approved the protocol. The study population
consisted of 20 patients with severe isolated AF referred
for mitral valve replacement in The First Hospital of
Anhui Medical University. Twenty patients of SR under-
went heart valve replacement surgery (Table 1). All se-
lected patients were classified as heart function, based
on the New York Heart Association (NYHA). During
surgical replacement of the mitral valve myocardial sam-
ples were obtained from the left atrial appendage. Part of
samples were immediately fixed in 10% buffered forma-
lin and embedded in paraffin for immunohistochemical
staining. The other samples were divided into pieces and
frozen separately in liquid nitrogen following different
processing for protein or RNA isolation.
Cell culture
The rat cardiac fibroblasts derive from SD neonate rats
and cultured. A part of heart tissue was washed by PBS.
Equal volumes of 0.25% trypsin and 0.3% type I collagen
enzyme were added, and heart tissue slices were incu-
bated in a 37 °C water bath. Cells were collected and the
collected cells were filtered with a screen stencil and
centrifuged at 1200 rpm for 5 min. Cells were seeded at
a concentration of 2 × 104 cells/cm2, and cultured with
DMEM containing 10% (v/v) fetal bovine serum, supple-
mented with 100U/ml penicillin, 100 mg/ml strepto-
mycin, 2 mM L-Glutamine, respectively. After four
passages, cells can be cultured with 5 ng/ml recombin-
ant murine TGF-β1 (Peprotech, USA). Cells were pas-
saged for 48 h and serum- starved with DMEM for 24 h.
Cell cultures were maintained at 37 °C in an atmosphere
of 5% CO2.
Table 1 Clinical characteristics of all patients including of 20 SR
patients and 20 AF patients
Group SR AF
Case (Male/Female) 20 (11/9) 20 (10/10)
Age (Year) 53.2 ± 10.5 46.7 ± 9.1
LVEF (%) 55.6 ± 6.9 56.8 ± 7.3
LAD (mm) 43.3 ± 4.2 58.1 ± 9.5**
NYHA-C (II/III/IV) 4/11/5 3/12/5
**Compared with SR group, P < 0.01
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Histological analysis
The rats were anesthetized and killed, hearts were
quickly isolated and the heart tissue fixed in 10% buff-
ered formalin. The left atrial appendage of the patients
done the same procedure. The heart tissue was excised.
Tissues were embedded in paraffin and cut into 5 μm
thick sections. They were mounted on normal glass
slides and stained with hematoxylin & eosin (H&E) and
Masson trichrome staining. Images of H&E-stained sec-
tions were used to measure cardiomyocyte width using
Olympus Image Pro-plus. Each section was assessed
under light microscopic fields.
Immunohistochemistry
The tissue sections were formalin fixed and paraffin em-
bedded prior to immunohistochemical staining. Sections
were deparaffinized, rehydrated, processed for antigen
retrieval. Sections were then incubated with primary
antibodies against α-SMA (1:400), CADM1 (1:300) and
p-STAT3 (1:200) overnight at 4 °C. After rinsing, the
sections were subsequently incubated with a biotinylated
goat anti-rabbit secondary antibody for 60 min at room
temperature, washed in PBS, and stained with DAB(3,
3′-diaminobenzidine). Slides were counterstained with
hematoxylin before dehydration and mounting. Negative
controls were run in parallel by replacing the primary
antibodies with PBS.
miR-21 mimic and inhibitor transfection
miR-21 mimic, inhibitor and their respective negative
control oligonucleotides were designed and chemically
synthesized by Biomics Biotechnologies (Nantong, China).
The sequences: miR-21 mimic sense 5′-UAGCUUAUCA
GACUGAUGU UGA -3′and anti-sense 5′-UCAACAU
CAGUCUGAUAAGCUA-3′, miR-21 inhibitor sequences
were 5′-UCAACAUCAGUCUGAUAAGCUA-3′. Cardiac
fibroblasts was prepared 24 h in antibiotic-free medium
before transfection and cultured into six-well plate to
achieve >70% confluence on the day of transfection. The
miR-21 mimic, inhibitor or their respective NC was
transfected into cells using Lipofectamine™ 2000 Reagent
(Invitrogen, Carlsbad, CA, USA) in serum-free conditions
for 4–6 h before changing to complete medium. The
transfected cells were cultured in regular culture medium,
and RNA and protein were collected 48–72 h after trans-
fection, respectively.
One-step qRT-PCR
To detect the expression of miR-21 in human atrial tis-
sues, rat heart tissues and cardiac fibroblasts, qRT-PCR
was carried out using the ABI 7500 Real Time PCR
system (Foster City, CA, USA). Total RNAs were ex-
tracted through one-step method with Trizol (Invitrogen,
USA). RNA-concentration was determined by IMPLEN
NanoPhotometer. One-step real-time qPCR was per-
formed to confirm expression of miR-21, it was measured
using EzOmics miRNA qPCR Detection Primer Set
(Biomics, USA) and EzOmics One-Step qPCR Kit
(Biomics, USA). PCR was performed at 42 °C for 30 min;
95 °C for 10 min, followed by 40 cycles of amplification.
Analysis the miR-21 expression was performed using the
comparative CT method with U6 as endogenous controls,
and the test was repeated three times.
qRT-PCR
Total RNA was isolated from cells and tissues, and the
first-strand cDNA was synthesized using RT-PCR syn-
thesis kit according to the manufacturer's instructions.
PCR for mRNA of CADM1 and STAT3 were performed
by using RT-PCR kits. RT-PCR was carried out under
standard protocol using the following primers (Table 2).
PCR was performed at 42 °C for 30 min; 95 °C for
10 min, followed by 40 cycles of amplification. Analysis
the miR-21 expression was performed using the com-
parative CT method with β-actin as endogenous con-
trols, and the test was repeated three times.
Cell proliferation assay
Cell proliferation was determined by the 3-(4, 5-
dimethylthiazol-2-yl)-2, 4-diphenyl- tetrazolium bromide
(MTT) assay based on the formation of formazan from
MTT by metabolically active cells. The cells were seeded
in 96-well culture plates at a density of 5 × 103 cells per
well and transfected with miR-21 inhibitor and negative
control, respectively. Twenty four hours later, cell prolif-
eration was assessed. MTT was added to the medium at
a final concentration of 5 mg/ml for 4–6 h. The
Table 2 Primer sequences used for real time fluorescent
quantitative polymerase chain reaction
Target mRNA Primer Sequence
Rat CADM1 Forward 5'-TGGCGTTACCTT GGTAACC-3'
Reverse 5'-GGTGTTGAGCCCTTTCCAG-3'
Rat α-SMA Forward 5' TGGCCACTGCTGCTTCCTCTTCTT 3'
Reverse 5' GGGGCCAGCTTCGTCATACTCCT 3'
Rat STAT3 Forward 5'-CACCCATAGTGAGCCCTTGGA-3'
Reverse 5'-TGAGTGCAGTGACCAGGACAGA-3'
Rat β-actin Forward 5' TGG AATCCTGTGGCATCCATGAAAC 3'
Reverse 5' ACGCAGCTCAGT AACAGTCCG 3'
Human CADM1 Forward 5'-TCAACACGCCGTACTGTCTG -3'
Reverse 5'-GTGGGAGGAGGGATAGTTGTG -3'
Human STAT3 Forward 5'- GAAGAATCCAACAACGGCAG-3'
Reverse 5'- TCACAATCAGGGAAGCATCAC-3'
Human β-actin Forward 5'-GCTCGTCGTCGACAACGGCTC-3'
Reverse 5'-CAAACATGATCTGGGTCATCTTCTC-3'
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resulting formazan crystals were dissolved in 150 μl di-
methyl sulfoxide (DMSO), and measured at the optical
density (OD) of 490 nm on a microplate reader (Bio-Tek
EL, USA). All experiments were performed in triplicate
and repeated at least three times.
Cell cycle
Cell cycle analysis kit (Beyotime, China) for cell cycle
analysis. The cells were seeded at a density of 5 × 103
cells per well in 96-well culture plates and transfected
with miR-21 inhibitor and their negative control, re-
spectively. Cells were washed with cold PBS after fix-
ation, then stained with 0.5 ml of propidium iodide (PI)
staining buffer at 37 °C for 30 min in the dark. The cell
cycle analyses were performed on BD LSR flow cyt-
ometer. The phases of cell cycle were analyzed by
WinMDI software program. The experiments were per-
formed in triplicate.
Western blotting
Total protein samples were extracted, the protein con-
centration was detected using a BCA protein assay kit
(Boster, China). Total protein from samples were elec-
trophoresed on a 10% SDS-PAGE gel and blotted onto a
PVDF membrane. After blocking, the membrane was
probed with antibodies against CADM1, p-STAT3, α-
SMA, collagen I and β-actin diluted in TBS/Tween20
(0.075%). Visualization of the second antibody was
performed using a chemiluminescence detection proced-
ure, ECL-chemiluminescent kit, according to the manu-
facturer’s protocol. The integrated density of each band
was normalized to the corresponding β-actin band. β-
actin was used as loading control.
Statistical analysis
Experimental results are expressed as means ± SD. Stat-
istical analysis was performed by using the ANOVA or
the Student’s t test when appropriate. P value <0.05 was
considered significant. All experiments were performed
at least three times.
Results
Pathological changes
H&E staining revealed that the cardiomyocyte width was
increased in the ISO group compared with the vehicle
group (Fig. 1a) and Masson’s trichrome staining shown
that cardiac collagen significantly deposition compared
with the vehicle group (Fig. 1b). In sum, 1 week after
ISO treatment result in cardiac fibrosis in rat heart.
CADM1/STAT3 signal pathway activation in cardiac
fibrotic remodeling and fibroblast
Immunohistochemistry assay demonstrated that p-
STAT3 and α-SMA protein expression were significantly
increased in the model groups compared with the con-
trol (Fig. 2a). Moreover, immunohistochemistry assay
A
B
Fig. 1 Pathological change in isoprenaline-caused rat cardiac fibrosis model. A piece of the heart tissue from each rat in the ISO rat model was
fixed with formalin, and then it was embedded in paraffin. Thin sections were cut and stained with hematoxylin and eosin (H&E) (a), Masson’s
trichrome stain (b). Rats were grouped vehicle (control) rat hearts or ISO (fibrotic) rat hearts. Representative views from each group are presented.
The numbers in the views represent the groups of rats in the experiments





Fig. 2 (See legend on next page.)
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found that α-SMA protein expression was significantly
increased in the AF groups compared with the control
(Fig. 2a). qRT-PCR suggested that STAT3 and α-SMA
mRNA expressions in the rat model group and AF group
were increased significantly compared with the control
group (Fig. 2b; 2c). However, western blotting demon-
strated that CADM1 protein expression was significantly
decreased in the rat model group and AF group com-
pared with the control group (Fig. 2d; 2e). qRT-PCR
suggested that CADM1 mRNA expression in the rat
model group and AF group were decreased significantly
compared with the control group (Fig. 2d; 2e).
In vitro, western blotting and qRT-PCR shown that α-
SMA and STAT3 expression increased in activated
cardiac fibroblasts, which was treated with TGF-β1 com-
pared with control group. However, western blotting and
qRT-PCR found that CADM1 expression decreased in
activated cardiac fibroblasts, which was treated with
TGF-β1 compared with control group (Fig. 2f ).
miR-21 overexpression in cardiac fibrotic remodeling and
fibroblast
To gain the expression of miR-21 in cardiac fibrotic re-
modeling and fibroblast. One-step qRT-PCR assay dem-
onstrated that miR-21 expression in the rat model group
and AF group were increased significantly compared
with the control group (Fig. 3a). Moreover, One-step
qRT-PCR found that miR-21 expression increased
(See figure on previous page.)
Fig. 2 CADM1/STAT3 signal pathway activation in cardiac fibrotic remodeling and fibroblast. a p-STAT3 immunostaining on sections of vehicle rat
heart or ISO (fibrotic) rat hearts. Images show absence of p-STAT3 in vehicle rat heart and selective p-STAT3 expression located in fibrotic lesions
of diseased heart. Images show α-SMA staining localised selectively to smooth muscle cells lining vessels of vehicle rat heart and to myofibroblasts in
association with fibrotic lesions in diseased heart. Moreover, Images show α-SMA staining localised selectively to smooth muscle cells lining vessels of
SR heart and AF heart. b Rat heart tissues RNA was isolated, and STAT3, α-SMA expression were evaluated by qRT-PCR. c Human heart tissues RNA was
isolated, and STAT3, α-SMA expression were evaluated by qRT-PCR. d Rat heart tissues RNA and protein was isolated, CADM1 mRNA expression was
evaluated by qRT-PCR, CADM1 expression was analyzed by Western blotting. e Human heart tissues RNA and protein was isolated, CADM1 mRNA
expression was evaluated by qRT-PCR, CADM1 expression was analyzed by Western blotting. f Total protein and RNA isolated from 0, 24 and 48 h
cultures with TGF-β1 of rat CFs, STAT3, α-SMA and CADM1 expression were analyzed by Western blotting and qRT-PCR. Results are mean ± SD
of triplicate experiments. *p < 0.05, **p < 0.01 vs control (vehicle)
A
B
Fig. 3 miR-21 increased in activated cardiac fibroblasts and fibrotic remodeling. a The miR-21 expression was assayed in rat and human cardiac
fibrosis tissue. One Step Real-time PCR showed that miR-21 was significantly up-regulated in cardiac fibrosis tissue compared to vehicle tissue.
Moreover, One Step Real-time PCR showed that miR-21 was significantly up-regulated in AF tissue compared to SR tissue. b The miR-21 expression
was assayed in CFs stimulated with TGF-β1. One Step Real-time PCR showed that miR-21 was significantly increased in activated CFs compared to
control group cell. Data are representative of at least three separate experiments. *P < 0.05 versus control or Vehicle or SR
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during activated cardiac fibroblasts, which was treated
with TGF-β1 compared with control group (Fig. 3b).
Knockdown of miR-21 inhibits the cardiac fibroblast
proliferation
To explore the roles of miR-21 in regulating cardiac fi-
broblasts cell proliferation, we tested the effect of miR-
21 down-expression on the cell proliferation. By One-
step qRT-PCR, we found that the expression of miR-21
significantly decreased in the cells transfected with miR-
21 inhibitor compared with NC and vehicle (Fig. 4a).
The cardiac fibroblast that was transfected with miR-21
inhibitor had a significantly lower proliferation than the
NC and vehicle (Fig. 4b). Cell cycle distribution was ana-
lyzed by Flow cytometry analysis showed that anti-
proliferative activity of miR-21 inhibitor was possibly
due to induce G2/M phase arrest (Fig. 4c). These results
suggested that down-expression of miR-21 inhibits the
cardiac fibroblasts proliferation.
miR-21 negative control CADM1 expression
To further determine the underlying mechanism of miR-
21 during cardiac fibroblast activation. We began our




Fig. 4 Knockdown of miR-21 inhibits the cardiac fibroblasts proliferation. a One Step Real-time PCR showed that transfection miR-21 inhibitor
decreased the expression of miR-21 in cardiac fibroblasts. miR-21 inhibitor group is decreased significantly compare with vehicle group. b Cell
viability was determined using MTT assay. 3 × 105 cardiac fibroblasts cells were seeded in 96-well plates and transfected with 60 nM miR-21 inhibitor
(24 h, 48 h). Knockdown of miR-21 caused a significant inhibition of cell activation and proliferation in TGF-β1-treated cardiac fibroblasts and the results
were directly tested by MTT assay. c Cardiac fibroblasts cells were transfected with 60 nM miR-21 inhibitor for 48 h. Then cells were harvested and the
cell-cycle distribution was analyzed by Flow cytometry analysis. Data are representative of at least three separate experiments. *P < 0.05, **P < 0.01
versus Vehicle or Control; #P < 0.05 versus model




Fig. 5 miR-21 negative control CADM1 expression. a Real-time PCR showed that transfection miR-21 mimic decreased the expression of CADM1
mRNA in cardiac fibroblasts cells. miR-21 mimic group is decreased significantly compare with vehicle group. b Western blotting indicated that
transfection miR-21 mimic decreased the expression of CADM1 protein in cardiac fibroblasts cells. c Real-time PCR showed that transfection miR-
21 inhibitor increased the expression of CADM1 mRNA in cardiac fibroblasts cells. miR-21 inhibitor group is increased significantly compare with
vehicle group. d Western blotting indicated that transfection miR-21 inhibitor increased the expression of CADM1 protein in cardiac fibroblasts.
Data are representative of at least three separate experiments. *P < 0.05, **P < 0.01 versus vehicle
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CADM1 by miR networks in cardiac fibroblasts. To de-
termine if miR-21 might play a key role in the dysregula-
tion of the CADM1 expression. To explore the
functional role of miR-21 on CADM1 targets, activated
cardiac fibroblasts were transfected with miR-21mimics
or a NC-miR for 48 h. RNA and protein were analyzed
by PCR and Western blots, respectively. Interestingly,
we found that CADM1 protein was significantly de-
creased compared with the NC and vehicle (Fig. 5b).
Moreover, the mRNA level of CADM1 was significantly
decreased compared with the NC and vehicle (Fig. 5a).
However, knockdown of miR-21 with miR-21 inhibitor,
PCR and Western blotting assay shown that the mRNA
and protein level of CADM1 was significantly increased
compared with the NC and vehicle (Fig. 5c; 5d). These
results indicated that miR-21 as a potential regulator of
CADM1 in cardiac fibroblasts.
CADM1 inhibits STAT3 pathway activity
As mentioned above, miR-21 overexpression could en-
hance TGF-β1-induced cardiac fibroblasts activation by
regulating CADM1/STAT3 signal in vitro, and then, ac-
tivated cardiac fibroblasts were transfected with miR-
21inhibitor (60nM) or a NC-miRNA (60 nM) for 48 h.
The protein of CADM1 and STAT3 were detected by
western blotting, compared to the NC and vehicle
group, knockdown of miR-21 with miR-21 inhibitor,
results shown that the protein level of CADM1 was
significantly increased, and the protein level of p-STAT3
was significantly decreased (Fig. 6). Overexpression of
miR-21 with miR-21 mimic, results shown that the
protein level of CADM1 was significantly decreased, and
the protein level of p-STAT3 was significantly increased
(Fig. 6).
Discussion
Cardiac fibrosis could appear as a result of AF [16]. Ex-
cessive fibroblast activation and collagen production are
the major pathogenic mechanisms in the progression
cardiac fibrosis [16, 17]. Therefore, the present study
aimed to investigate the new mechanisms for cardiac
fibroblast proliferation and cardiac fibrosis. Firstly, we
evaluated the changes of pathological changes in the rat
hearts. Masson’s and H&E assay shown that cardiac fi-
brosis rat collagen significantly deposition compared
with the normal rat.
Abnormal expression of genes involved in cardiac
fibroblast activation and fibrosis. Our study indicated
that the mRNA and protein of STAT3 increased in acti-
vated fibroblast and fibrosis tissue. TGF-β1 induced fi-
broblasts activation and proliferation through STAT3.
However, CADM1 mRNA and protein expression was
significantly decreased in cardiac fibrosis tissue and
fibroblast. Studies demonstrated that CADM1 may in-
hibit STAT3 activity and control cellular proliferation.
Therefore, CADM1/STAT3 pathway is important for
cardiac fibrosis development.
Emerging evidence suggests that miR-21 regulation of
cardiac fibroblast activation and fibrosis [9, 18]. We
demonstrated that the expression of miR-21 increased in
cardiac fibroblast and fibrosis tissue. We also showed
that silencing of miR-21 can inhibit α-SMA expression.
Fig. 6 CADM1 inhibits STAT3 pathway activity. Western blotting indicated that transfection miR-21 mimic decreased the expression of CADM1
protein in cardiac fibroblasts cells. In addition, transfection miR-21 mimic increased the expression of p-STAT3 protein in cardiac fibroblasts cells.
However, transfection miR-21 inhibitor increased the expression of CADM1 protein in cardiac fibroblasts cells. Moreover, transfection miR-21
inhibitor decreased the expression of p-STAT3 protein in cardiac fibroblasts cells. Data are representative of at least three separate experiments.
*P < 0.05, **P < 0.01 versus vehicle
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Furthermore, the cell proliferation assay suggested that
miR-21 inhibitors can suppress cardiac fibroblasts prolif-
eration. However, it remains unclear whether miR-21
has an effect on CADM1 in cardiac fibroblast activation
and fibrosis, we found that miR-21 overexpression corre-
lated with CADM1/STAT3 in cardiac fibroblasts.
miRs therapy can control CADM1/STAT3 pathway,
we examined what changes of CADM1/STAT3, after
treatment cardiac fibroblasts with miR-21 mimics and
inhibitors. Our experiment found that miR-21 may con-
trol CADM1 expression. Moreover, these data indicated
that miR-21 suppress CADM1 may result in upregula-
tion of STAT3 expression.
In sum, we found that miR-21 contribute to fibroblast
proliferation and cardiac fibrosis via CADM1/STAT3
pathway. Our findings showed that miR-21 and CADM1
play a key role in cardiac fibrosis, indicating that miR-
21, CADM1 and STAT3 may serve as therapeutic target
of fibroblast activation and fibrosis. More importantly,
we showed that miR-21 can inhibit cardiac fibroblasts
proliferation, through regulation of the CADM1/STAT3
pathway, mediated by miR-21 and the targeting of the
CADM1.
Conclusions
Our findings indicated that miR-21 and CADM1 are in-
volved in the pathogenesis of cardiac fibrosis, implicating
that miR-21, CADM1 and STAT3 signaling pathway
molecules could be used as therapeutic target of cardiac
fibrosis. miR-21 can inhibit cardiac fibroblasts prolifera-
tion, through the CADM1/STAT3 pathway, mediated by
miR-21, targeting CADM1.
Abbreviation
AF: Atrial fibrillation; CADM1: Cell adhesion molecule 1; CVF: Collagen
volume fraction; DMSO: Dimethyl sulfoxide; ISO: Isoprenaline;
miRNA: MicroRNA; NC: Negative control; OD: Optical density; SR: Sinus
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